megaTALs: a rare-cleaving nuclease architecture for therapeutic genome engineering
Sandrine Boissel(University of Washington), Andrew M. Scharenberg(CTI BioPharma (Italy)), Andrew Adey(Oregon Health & Science University), Agnès Gouble(Txcell (France)), David Baker(Howard Hughes Medical Institute), Barry Stoddard(Fred Hutch Cancer Center), Philippe Duchâteau(Hôpital de la Croix-Rousse), Alexander Astrakhan(Seattle University), Jay Shendure(Brotman Baty Institute), Michael T. Certo(University of Washington), Jordan Jarjour(Biogen (United States))
Cited by 174
Related Papers
A general framework for estimating the relative pathogenicity of human genetic variants
|Nature Genetics|2014|6.5k
The single-cell transcriptional landscape of mammalian organogenesis
|Nature|2019|4.7k
Protein structure prediction and analysis using the Robetta server
|Nucleic Acids Research|2004|2.2k
De novo design of protein structure and function with RFdiffusion
|Nature|2023|1.9k